LSD and Brain Connections

June 13, 2023 Lynne Nardizzi

This study, published in the Journal of Psychopharmacology, found that LSD “not only increases the strength of certain brain connections but weakens other connections at the same time,” according to a digest of the study in Psychedelic Spotlight.

Ethics and Psychedelics

June 11, 2023 Lynne Nardizzi

This study presents a range of ethical issues that arise when considering the use of psychedelic substances within medicine.

Psychedelics are, by their nature, boundary-dissolving, and it is suggested that progress in the Ethics of Psychedelic Medicine is best made within a broader-ranging Psychedelic Bioethics, which encompasses not just medicine, but wider society, including the breadth of cultural containers and settings in which these compounds are used.

Psychedelics, Alcoholism and PTSD

June 10, 2023 Lynne Nardizzi

This study evaluated prospective associations of ibogaine and 5-MeO-DMT treatment for risky alcohol use and post-traumatic stress disorder (PTSD) symptoms among United States (US) Special Operations Forces Veterans (SOFV).

Future clinical trials should determine whether psychedelic-assisted therapy holds promise for individuals with complex trauma and alcohol misuse who have not been successfully treated with traditional interventions.

Psychedelics... Legal Soon?

June 9, 2023 Lynne Nardizzi

Psychedelics may be part of U.S. medicine sooner than you think!

More on the Therapeutic Potential of Mushrooms

June 8, 2023 Lynne Nardizzi

Fred Barrett, a neuroscientist at the Johns Hopkins Center for Psychedelic & Consciousness Research, discusses the revolutionary healing potential of psilocybin, what is not yet known about the compound’s role in treating various psychiatric disorders, the importance of the “therapy” aspect of psychedelic-assisted therapy, and the hurdles that remain to this treatment being accessible to the general public.

Psychedelics and Antidepressants

June 7, 2023 Lynne Nardizzi

5 Questions for psychopharmacologist Kelan Thomas. Thomas discusses what we know — and don’t know — about potential interactions between psychedelics and SSRIs.

Studying Psychedelics- Design and Research

June 6, 2023 Lynne Nardizzi

How much does a person’s subjective experience and expectation of a psychedelic trip, as opposed to only the drug’s chemical effects on the brain, influence the drug’s ability to alleviate conditions like depression, addiction, or post-traumatic stress disorder?

Now that psychedelics are being noticed by federal regulators and the public, scientists are again asking: What’s the best way to study these compounds in order to truly understand their effects?